TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Genetic Technologies ( (AU:GTG) ) is now available.
Genetic Technologies Limited has announced significant changes in its board and executive management. Michael Walker has been appointed as the Executive Chairman and Managing Director, while William Musgrave joins as a non-executive director, bringing extensive commercial and legal experience. Additionally, Jules Grove has been appointed as the Chief Financial Officer, and Priyamvada Rasal as the Joint Company Secretary. These appointments are expected to strengthen the company’s leadership and support its strategic growth initiatives.
More about Genetic Technologies
Genetic Technologies Limited operates in the biotechnology industry, focusing on genetic testing and diagnostics. The company is known for its innovative genetic testing products and services, which are aimed at improving health outcomes and advancing personalized medicine.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.45M
For a thorough assessment of GTG stock, go to TipRanks’ Stock Analysis page.